The EPS projection of HCA Holdings, Inc. (NYSE:HCA) for quarter ended 2016-09-30 is $1.44. Last week, the projection for EPS was $1.44 against target of $1.44, a month earlier. While 2-months ago, this projection was $1.44 versus forecast of $1.44a quarter months earlier, posting a deviation of 0%.
HCA Holdings, Inc. (NYSE:HCA) posted that 18 days earlier, the share price was revised 8 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 1. While in last 120 and 90 days, positive revisions were 5, and 5, correspondingly.
The per-share earnings downgrade for HCA Holdings, Inc. (NYSE:HCA) in the preceding 30 and 120 were 0 and 5. While in 60 and 90 days were 1, and 5, in that order.
HCA Holdings, Inc. (NYSE:HCA) EPS target was $1.44 for the quarter closed 1. It was based on 13 calls. As on 2016-05-03 the EPS was $1.71. The change was $0.22, posting a deviation of 14.77%. The price projections gave a standard deviation of 0.04.
Quarterly Sales Estimates
HCA Holdings, Inc. (NYSE:HCA) sales prediction for the fiscal 2017 stands at $11353.4 and the median estimate is at $11358. Almost 5 analysts gave sales target.
Among this, the highest sales estimate is $11474 while the lowest target is $11222 showing standard deviation of 96.378%.
As many as 5 analysts have positive sales targets revision while 5 reduced sales estimates, posting a deviation of 0%.
Last month, 5 experts have positive sales number revision. Also, 5 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast, posting a deviation of 0.075%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...